Role of hERG potassium channel assays in drug development

Birgit T Priest1, Ian M Bell, Maria L Garcia

  • 1Department of Ion Channels, Merck Research Laboratories, Rahway, New Jersey, USA. birgit_priest@merck.com

Channels (Austin, Tex.)
|October 14, 2008
PubMed

Insights

Screening drug candidates for hERG channel activity early is crucial. This prevents costly failures due to QT prolongation and potential cardiac arrhythmias, ensuring safer drug development.

Area of Science:

  • Pharmacology
  • Cardiology
  • Drug Safety

Background:

  • The hERG potassium channel is vital for cardiac repolarization.
  • Drug-induced blockade of hERG channels can lead to QT prolongation and fatal arrhythmias.
  • Early identification of hERG activity is essential to mitigate drug development risks.

Purpose of the Study:

  • To highlight the importance of early screening for hERG channel activity in drug discovery.
  • To discuss available methods for assessing hERG channel interactions.
  • To guide efficient structure-function relationship development for hERG inhibitors.

Main Methods:

  • Utilizing a range of assays, from high-throughput binding assays to detailed electrophysiological studies.
  • Employing functional assays such as membrane potential or rubidium flux measurements.
  • Integrating binding and functional assays with electrophysiology for comprehensive evaluation.

Main Results:

  • hERG channel blockade by diverse drug classes is a significant safety concern.
  • Early screening identifies compounds likely to cause QT prolongation.
  • A combination of screening methods allows for efficient structure-activity relationship determination.

Conclusions:

  • Early and thorough screening of drug candidates for hERG channel activity is paramount for preclinical safety.
  • A tiered approach using various assays can optimize the identification of safe drug leads.
  • Understanding hERG interactions early streamlines lead optimization and reduces late-stage attrition.

Related Concept Videos

Patch Clamp01:18

Patch Clamp

Many fundamental cell functions such as muscle contraction and nerve transmission rely on the electrical signals produced by the movement of positively and negatively charged ions across the cell membrane. One competent method to record current flowing across the whole cell or single ion channel is the patch-clamp technique.
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...
Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Non-gated Ion Channels01:24

Non-gated Ion Channels

Ion channels are specialized proteins on the plasma membrane that allow charged ions to pass down their electrochemical gradient. Their main function is to maintain the membrane potential which is critical for cell viability. These channels are either gated or non-gated and can transport more than a thousand ions within milliseconds for the cellular event to occur.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism.
G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory organs,...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...